NORMOCARB HF 25
MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
Approval overview NORMOCARB HF 25 is listed in Drugs@FDA under application 021910 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE Form and strength SOLUTION;INJECTION - 0.21GM/100ML;2.8GM/100ML;9.07GM/100ML Sponsor DIALYSIS SUPS Submission history Latest submission status date: 2019-05-01 00:00:00.
Structured Monograph
Clinical summary
Approval overview NORMOCARB HF 25 is listed in Drugs@FDA under application 021910 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE Form and strength SOLUTION;INJECTION - 0.21GM/100ML;2.8GM/100ML;9.07GM/100ML Sponsor DIALYSIS SUPS Submission history Latest submission status date: 2019-05-01 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.